Key Takeaway
Curious about peptide therapy but unsure what it costs? The peptide therapy cost varies widely based on which peptide you use, your dosing protocol, and where you get it. Some protocols run under $100 per month. Others can exceed $500.
Curious about peptide therapy but unsure what it costs? The peptide therapy cost varies widely based on which peptide you use, your dosing protocol, and where you get it. Some protocols run under $100 per month. Others can exceed $500. Knowing the real numbers upfront helps you budget properly and avoid surprises.
Key Takeaways: - Average Monthly Costs by Peptide - Understand what drives peptide pricing differences - Building Your Monthly Peptide Budget - Insurance, HSA/FSA, and Payment Options
This guide breaks down pricing for the most popular peptides, explains what drives cost differences, and shows you how to build a realistic monthly budget.
Average Monthly Costs by Peptide
Here are typical monthly price ranges for the most commonly prescribed peptides through licensed telehealth providers and 503A pharmacies.
BPC-157 (Body Protection Compound): - Typical dose: 250-500 mcg, 1-2x daily - Monthly cost: $80-200 - Protocol length: 4-12 weeks - Learn more in our
TB-500 (Thymosin Beta-4): - Typical dose: 2-5 mg, 2-3x per week - Monthly cost: $100-250 - Protocol length: 4-12 weeks
BPC-157 + TB-500 Stack ("Wolverine Stack"): - Combined monthly cost: $150-400 - Protocol length: 6-12 weeks - Learn more in our
CJC-1295 + Ipamorelin (Growth Hormone Peptides): - Typical dose: 100-300 mcg each, daily - Monthly cost: $150-350 - Protocol length: 3-6 months
"The key to successful GLP-1 therapy is setting realistic expectations and supporting patients through the titration phase. The side effects are manageable for most people, but they need to know what to expect.") Dr. Caroline Apovian, MD, Harvard Medical School
GHK-Cu: - Typical dose: 200-600 mcg daily - Monthly cost: $80-180 - Protocol length: 4-12 weeks
These ranges include the medication cost from a licensed compounding pharmacy. Provider consultations, supplies, and shipping may be additional.
Check for current rates on all available peptides.
What Drives Peptide Pricing Differences
Why does the same peptide cost $80 at one provider and $250 at another? Several factors explain the variation.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
Pharmacy sourcing. Different compounding pharmacies charge different prices based on their cost of raw materials, overhead, and quality testing protocols. Pharmacies with more rigorous testing may charge more (but you're paying for verified quality.
Dose and protocol length. A 250 mcg once-daily BPC-157 protocol costs roughly half as much as 500 mcg twice-daily. Your provider sets the dose based on clinical need, not cost) but understanding the relationship helps you budget.
Patient Perspective: "My insurance denied Wegovy twice. My provider helped me file a peer-to-peer review appeal with supporting documentation from my labs and BMI history. Third time was approved. Don't give up after the first denial.", Brian C., 45, FormBlends patient (name changed for privacy)
Free Download: GLP-1 Cost Comparison Spreadsheet Includes a peptide therapy budget calculator alongside GLP-1 pricing. Map out your total monthly treatment costs. Get yours free (we'll email it to you instantly.
[Download CTA Button]
Vial size and concentration. Larger vials may offer a lower cost per milligram. But remember: reconstituted peptides last about 28 days. A vial that contains more than 28 days of doses means unused medication goes to waste. Match vial size to your protocol. Use the to plan.
Provider platform fees. Some providers charge a flat monthly fee that includes everything. Others charge separately for consultations, medication, and supplies. Compare total monthly costs, not just medication prices.
Stacking multiple peptides. Running two or more peptides simultaneously doubles (or more) your medication cost. Some stacking protocols can be sequential rather than simultaneous) finishing one peptide before starting another (which spreads costs over time.
Building Your Monthly Peptide Budget
A complete peptide therapy budget includes more than just the medication. Here's a realistic breakdown.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →Single peptide protocol (e.g., BPC-157 alone): | Expense | Monthly Cost | |---------|-------------| | Medication (one peptide) | $80-200 | | Provider consultation | $0-75 (may be included) | | Supplies (syringes, BAC water, swabs) | $10-20 | | Shipping | $0-15 (may be included) | | Total | $90-310 |
Dual peptide protocol (e.g., BPC-157 + TB-500): | Expense | Monthly Cost | |---------|-------------| | Medications (two peptides) | $150-400 | | Provider consultation | $0-75 | | Supplies | $15-30 | | Shipping | $0-15 | | Total | $165-520 |
Growth hormone peptide protocol (CJC-1295 + Ipamorelin): | Expense | Monthly Cost | |---------|-------------| | Medications (two peptides) | $150-350 | | Provider consultation | $0-75 | | Lab work (periodic) | $0-100 (not every month) | | Supplies | $15-30 | | Shipping | $0-15 | | Total | $165-570 |
HSA/FSA adjustment: Multiply your total by 0.65-0.80 (depending on your tax bracket) to get your effective after-tax cost if paying with pre-tax health account funds.
Offers transparent, all-inclusive pricing for peptide protocols. No surprise fees.
Insurance, HSA/FSA, and Payment Options
Let's be direct: most insurance plans don't cover peptide therapy. Peptides are typically paid out of pocket. But there are ways to reduce the financial impact.
HSA/FSA eligibility. Prescribed peptides from a licensed provider and pharmacy generally qualify as HSA/FSA eligible expenses. This reduces your effective cost by 20-35%.
Payment plans. Some providers offer monthly payment plans or subscriptions that spread the cost over time.
Protocol improvement. Your provider can help you design the most cost-effective protocol. This might mean a shorter intensive phase followed by a longer break, or choosing the most cost-effective peptide for your specific goal.
Sequential vs. Simultaneous protocols. If budget is a concern, consider running peptides sequentially (one at a time) rather than simultaneously. Discuss this approach with your to ensure it still meets your clinical goals.
Multi-month purchasing. Some pharmacies offer savings on 2-3 month supplies. If you know your protocol length, buying ahead can reduce per-month costs.
The helps you track your protocol and doses, ensuring you get the most out of every vial and don't waste medication.
Frequently Asked Questions
Is peptide therapy worth the cost?
The value depends on your specific situation and goals. For people using BPC-157 for injury recovery, the cost may be offset by reduced physical therapy visits and faster return to activity. For growth hormone peptide users, the benefits may include improved sleep, recovery, and body composition. Discuss expected outcomes with your provider to evaluate whether the investment aligns with your goals.
Why don't insurance companies cover peptide therapy?
Most peptides prescribed through compounding pharmacies are used for indications that insurers consider "off-label" or experimental. Unlike GLP-1 medications, which have large-scale clinical trials supporting FDA-approved indications, most peptide therapy relies on smaller studies and clinical experience. This makes insurance coverage unlikely in the near term.
How can I reduce my peptide costs without sacrificing quality?
Work with your provider to improve your protocol length and dosing. Choose the right vial size for your protocol duration. Pay with HSA/FSA funds for tax savings. Consider sequential rather than simultaneous stacking. And always use a licensed provider and pharmacy) "cheap" peptides from unregulated sources carry safety risks that far outweigh any savings.
What is the cheapest peptide therapy available?
BPC-157 at a standard dose of 250 mcg once daily is typically the most affordable peptide protocol, often running $80-150 per month. GHK-Cu is also relatively affordable. Growth hormone peptide protocols tend to be more expensive because they involve two peptides used daily over longer timeframes.
Your Personalized Plan Is Waiting
No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.
Medical References
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. [PubMed | DOI]
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]
Sources &. References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[5] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
- Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[6] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[7] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
- Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
- Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections, United States, 2012. MMWR. 2012;61(41):839-842.
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.
Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.
Last updated: 2026-03-24